الصفحة 1
الصفحة 1
Non-Linear Optical Properties of Matte : From molecules to condensed phases
Non-Linear Optical Properties of Matter: From Molecules to Condensed Phases attempts to draw together both theory and application in this field. As such it will be of interest to both experimentalists and theoreticians alike. Divided into two parts, Part 1 is concerned with the theory and computing of non-linear optical (NLO) properties while Part 2 reviews the latest developments in experimentation.This book will be invaluable to researchers and students in academia and industry. It will be of particular interest to anyone involved in materials science, theoretical and computational chemistry, chemical physics, and molecular physics.
Advanced Quantum Mechanics
Discusses nonrelativistic multi-particle systems, relativistic wave equations and relativistic quantum fields. Characteristic of the author´s work are the comprehensive mathematical discussions in which all intermediate steps are derived and where numerous examples of application and exercises help the reader gain a thorough working knowledge of the subject. The topics treated in the book lay the foundation for advanced studies in solid-state physics, nuclear and elementary particle physics. This text both extends and complements Schwabl´s introductory Quantum Mechanics, which covers nonrelativistic quantum mechanics and offers a short treatment of the quantization of the radiation field. The fourth edition has been thoroughly revised with new material having been added. Furthermore, the layout of the figures has been unified, which should facilitate comprehension.
A short guide to clinical pharmacokinetics
Consists of seven chapters that cover various aspects of pharmacokinetics and its clinical applications. The chapters are structured to provide clear objectives and keywords are bolded throughout the text to facilitate understanding. The topics covered include the significance of pharmacokinetics in clinical practice, factors affecting pharmacokinetic parameters, pharmacokinetic drug interactions, therapeutic drug monitoring, dosage adjustment in different population groups, the influence of hepatic diseases on pharmacokinetics and the impact of pharmacogenomics on pharmacokinetics and pharmacodynamics.
